Gilead Science releases pricing plan for COVID-19 drug Remdesivir - One America News Network

1. Gilead Science releases pricing plan for COVID-19 drug Remdesivir  One America News Network
2. Gilead sets U.S. price for Covid-19 drug remdesivir at $3120 for typical treatment  CNBC Television
3. Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations  Yahoo Finance
4. Gilead Sets a Good-Enough Bar With Covid-Treatment Price  Bloomberg
5. Dr. Marc Siegel: Coronavirus defense — as numbers rise, promising drug Remdesivir cleared for use  Fox News
6. View Full Coverage on Google News